Table 1

Characteristics of the trials and sample

ReferenceCountryDrugSampleGroupsAgePhaseDesignDurationDosageOutcome
Authors, yearCountries where the trial was carried outDrug usedNumber of participantsNumber of participants in each groupAge (SD or max/min)Phase of the clinical trialRCT, non-RCT, open label or blinded, crossoverDuration of the trialDosage of drug in each groupMeasures of trial outcomes
  • RCT, randomized contolled trial; SD, standard deviation.